Fact CheckerSign in

NCT07050329Completed

Comparison of Operation Time, Drain Duration, and Seroma Formation After Modified Radical Mastectomy Using Ultrasonic Dissector Versus Electrocautery in Women With Breast Cancer

Comparison of Outcome With Ultrasonic Dissector Versus Electrocautery in Modified Radical Mastectomy

Source: ClinicalTrials.gov · Last updated 3 Jul 2025

Brief summary (registry, in English)

The goal of this clinical trial was to compare two surgical techniques-ultrasonic dissector and electrocautery-for performing axillary dissection in women undergoing modified radical mastectomy (MRM) for breast cancer. The study aimed to determine whether using an ultrasonic dissector reduces operation time, the number of days surgical drains remain in place, and the frequency of seroma formation compared to conventional electrocautery. The main questions the study aims to answer are: 1. Does the ultrasonic dissector reduce the duration of surgery compared to electrocautery? 2. Do patients operated with an ultrasonic dissector require surgical drains for fewer days? 3. Is the frequency of postoperative seroma formation lower in the ultrasonic dissector group? Researchers randomly (1:1) assigned 138 women with breast cancer (aged 35-65 years) undergoing MRM to either the ultrasonic dissector group or the electrocautery group. All surgeries were performed by experienced consultant surgeons using standardized protocols. Participants: * Underwent MRM with either electrocautery or ultrasonic dissector for axillary dissection * Were discharged 24 hours after surgery with two drains in place * Measured and reported daily drain output at home * Returned for weekly follow-up for 30 days postoperatively Outcomes were measured by recording the operation time, the number of days drains remained in place, and the occurrence of seroma. The results would help guide surgical practice by identifying the safer and more efficient dissection method during MRM.

Status (registry)
Completed
Study type
Interventional
Enrollment
138 (actual)
First submitted
25 Jun 2025
Start date
4 Jun 2024
Primary completion date
3 Dec 2024
Lead sponsor
Quaid-e-Azam Medical College
NCT number
NCT07050329

What you commit to

  • Study type: Interventional
  • Participants enrolled: 138
  • From 4 Jun 2024 to the primary completion date, 3 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Women with previous radiation over chest wall

Other illness

  • Women with recurrent breast cancer and

Other

  • Planned with immediate reconstruction

Who the study is looking for

  • Diagnosed with breast cancer and
  • Planned for modified radical mastectomy

Age in the registry: 35 years to 65 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Quaid-e-Azam Medical College
Coordinator of this site? Confirm its status
BahawalpurPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.